Published in J Clin Microbiol on March 26, 2008
Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli. J Clin Microbiol (2009) 1.01
NBC update: The addition of viral and fungal databases to the Naïve Bayes classification tool. BMC Res Notes (2012) 0.78
Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients. J Clin Microbiol (2016) 0.75
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (2002) 6.99
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis (2001) 2.15
Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol (2004) 1.59
Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol (2005) 1.28
Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. J Clin Microbiol (2005) 1.10
Fungal infection in lung transplantation. Transpl Infect Dis (2002) 0.91
Identification of Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides species by repetitive-sequence-based PCR. J Clin Microbiol (2006) 0.89
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis (2005) 4.31
Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol (2005) 2.22
Clinical and laboratory update on blastomycosis. Clin Microbiol Rev (2010) 2.01
Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J Clin Microbiol (2005) 1.75
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Comparison of six methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing by quantitative real-time PCR. J Clin Microbiol (2005) 1.69
Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol (2003) 1.62
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother (2005) 1.55
Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence-based PCR for characterization of Staphylococcus aureus strains. J Clin Microbiol (2005) 1.53
IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc (2014) 1.48
Comparison of typing results obtained for methicillin-resistant Staphylococcus aureus isolates with the DiversiLab system and pulsed-field gel electrophoresis. J Clin Microbiol (2009) 1.40
Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int J Syst Evol Microbiol (2006) 1.34
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. Clin Infect Dis (2002) 1.23
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study. Clin Infect Dis (2002) 1.16
Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol (2012) 1.12
Predicting Salmonella enterica serotypes by repetitive sequence-based PCR. J Microbiol Methods (2008) 1.11
Repetitive-sequence-PCR-based DNA fingerprinting using the Diversilab system for identification of commonly encountered dermatophytes. J Clin Microbiol (2005) 1.10
Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens. Diagn Microbiol Infect Dis (2004) 1.10
In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates. J Clin Microbiol (2013) 1.06
Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat. Am J Physiol Renal Physiol (2004) 1.04
Safety and tolerability of ertapenem. J Antimicrob Chemother (2004) 1.03
Multiplex single-color PCR with amplicon melting analysis for identification of Aspergillus species. Clin Chem (2006) 0.99
Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J (2012) 0.96
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. J Subst Abuse Treat (2011) 0.96
Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study. Antimicrob Agents Chemother (2002) 0.96
Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation. Nitric Oxide (2007) 0.95
Clinical evaluation of repetitive sequence-based polymerase chain reaction using the Diversi-Lab System for strain typing of vancomycin-resistant enterococci. Diagn Microbiol Infect Dis (2006) 0.92
Comparison of real-time polymerase chain reaction using the Smart Cycler and the Gen-Probe amplified Mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in clinical specimens. Diagn Microbiol Infect Dis (2006) 0.92
Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreak. J Clin Microbiol (2008) 0.92
Detection of strain variation in isolates of Rhodococcus equi from an affected foal using repetitive sequence-based polymerase chain reaction. J Vet Diagn Invest (2010) 0.90
Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000. Infect Control Hosp Epidemiol (2003) 0.90
Use of surrogate antimicrobial agents to predict susceptibility to ertapenem. Diagn Microbiol Infect Dis (2002) 0.89
Identification of Histoplasma capsulatum, Blastomyces dermatitidis, and Coccidioides species by repetitive-sequence-based PCR. J Clin Microbiol (2006) 0.89
Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR. J Med Microbiol (2007) 0.88
Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. Diagn Microbiol Infect Dis (2003) 0.87
Is HIV infection a risk factor for complications of surgery? Mt Sinai J Med (2002) 0.87
Comparison of traditional phenotypic identification methods with partial 5' 16S rRNA gene sequencing for species-level identification of nonfermenting Gram-negative bacilli. J Clin Microbiol (2010) 0.87
Molecular characterization of hand flora and environmental isolates in a community setting. J Clin Microbiol (2005) 0.86
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections. J Infect (2004) 0.86
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy. J Antimicrob Chemother (2004) 0.86
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study. Infect Dis Obstet Gynecol (2003) 0.85
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. J Antimicrob Chemother (2003) 0.84
Interpretive criteria for use of AccuProbe for identification of Mycobacterium avium complex directly from 7H9 broth cultures. J Clin Microbiol (2005) 0.83
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections. Surg Infect (Larchmt) (2002) 0.83
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. Int J Antimicrob Agents (2002) 0.82
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. J Acquir Immune Defic Syndr (2004) 0.81
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. J Antimicrob Chemother (2004) 0.81
Sequence variant for internal transcribed spacer region of Mycobacterium abscessus. J Clin Microbiol (2005) 0.80
Sleep and daytime sleepiness of patients with left ventricular assist devices: a longitudinal pilot study. Prog Transplant (2011) 0.79
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. J Antimicrob Chemother (2002) 0.79
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam. Surg Infect (Larchmt) (2002) 0.79
Ertapenem as initial antimicrobial monotherapy for patients with chronic obstructive pulmonary disease hospitalized with typical community-acquired pneumonia. Pulm Pharmacol Ther (2004) 0.78
"What made me stay?" A review of the reasons student nurses enrolled in a Bachelor of Nursing programme completed their studies: a descriptive phenomenological study. Nurse Educ Today (2012) 0.78
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies. J Antimicrob Chemother (2004) 0.77
Clinical pharmacist intervention for patients with left ventricular assist devices. Ann Pharmacother (2011) 0.76
Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese University Hospital between 1987 and 2004. J Infect Chemother (2011) 0.76
Recovery of live virus after storage at ambient temperature using ViveST™. J Clin Virol (2012) 0.75
Comparison of bromcresol purple and capillary protein electrophoresis for quantification of serum albumin in multiple myeloma. Clin Chem (2009) 0.75
A bounding estimate of neutron dose based on measured photon dose around single pass reactors at the Hanford site. Health Phys (2010) 0.75
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam. Int J Antimicrob Agents (2004) 0.75
Polypharmacy reduction in youth in a residential treatment center leads to positive treatment outcomes and significant cost savings. J Child Adolesc Psychopharmacol (2013) 0.75
Mycobacteria. Microbiol Spectr (2016) 0.75
An exploratory study of sleep quality, daytime function, and quality of life in patients with mechanical circulatory support. Int J Artif Organs (2012) 0.75
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. Diagn Microbiol Infect Dis (2002) 0.75
A 66-year-old woman with fever, cough, and a tongue lesion. Chest (2015) 0.75